A detailed history of 1832 Asset Management L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, 1832 Asset Management L.P. holds 450,186 shares of NVO stock, worth $47.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
450,186
Previous 1,620,786 72.22%
Holding current value
$47.4 Million
Previous $231 Million 76.83%
% of portfolio
0.1%
Previous 0.44%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $139 Million - $170 Million
-1,170,600 Reduced 72.22%
450,186 $53.6 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $92.3 Million - $111 Million
-752,243 Reduced 31.7%
1,620,786 $231 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $17.6 Million - $23.4 Million
172,003 Added 7.81%
2,373,029 $305 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $23.6 Million - $28.4 Million
269,158 Added 13.93%
2,201,026 $228 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $176 Million - $385 Million
1,931,868 New
1,931,868 $176 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $182 Million - $201 Million
1,165,434 New
1,165,434 $189 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $32,490 - $39,873
-341 Reduced 0.12%
279,938 $27.9 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $4,749 - $5,603
46 Added 0.02%
280,279 $31.2 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $859,313 - $1.04 Million
9,230 Added 3.41%
280,233 $30.7 Million
Q4 2021

Feb 15, 2022

SELL
$95.88 - $117.08 $7.22 Million - $8.82 Million
-75,335 Reduced 21.75%
271,003 $30.5 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $29.2 Million - $36.9 Million
346,134 Added 169673.53%
346,338 $33.5 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $6,089 - $7,628
90 Added 78.95%
204 $17,000
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $17,514 - $19,310
-275 Reduced 70.69%
114 $8,000
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $16,098 - $18,683
275 Added 241.23%
389 $25,000
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $2,792 - $3,262
-56 Reduced 32.94%
114 $7,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $2,662 - $2,992
56 Added 49.12%
170 $9,000
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $2,339 - $2,623
-50 Reduced 30.49%
114 $6,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $7,263 - $8,268
164 New
164 $8,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.